ZVSA

ZyVersa Therapeutics Inc

0.394
0.019 (5.07%)

ZyVersa Therapeutics Inc. (ZVSA) Fundamentals

ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medical needs, with emphasis on inflammatory and renal diseases.
SHARE INFORMATION
Market CapUS$ 7,685,600
Shares Outstanding20,225,263
Float4,235,991
Percent Float20.94%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -0.99
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions4
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months-
Institutional Holdings Percent1.1%
Institutional Sold Previous 3 Months-
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months100,000
Insider Holdings Percent1.1
Insider Sold Previous 3 Months-
Insider Shares Owned100,000
TRADING INFO
52 Week HighUS$ 25.00
52 Week LowUS$ 0.36
52 Week High ChangeUS$ -96.18
21 Day Moving AverageUS$ 0.4408
21 Day Extended Moving AverageUS$ 0.516696
50 Day Moving AverageUS$ 1.0613
50 Day Extended Moving AverageUS$ 0.998139
200 Day Moving AverageUS$ 5.1857
200 Day Extended Moving AverageUS$ 4.1362
10 Day Average Volume2,335,286
20 Day Average Volume2,082,320
30 Day Average Volume2,953,696
50 Day Average Volume1,800,427
Alpha-0.101964
Beta0.7286
Standard Deviation0.300118
R20.022547
7 Day Price ChangeUS$ -0.0154
7 Day Percent Change-3.89%
21 Day Price ChangeUS$ -0.0523
21 Day Percent Change-12.1%
30 Day Price ChangeUS$ -0.1816
30 Day Percent Change-32.34%
Month to Date Price ChangeUS$ 0.014
Month to Date Percent Change3.83%
Quarter to Date Price ChangeUS$ -1.55
Quarter to Date Percent Change-80.31%
180 Day Price ChangeUS$ -9.83
180 Day Percent Change-96.28%
200 Day Price ChangeUS$ -9.73
200 Day Percent Change-96.24%
Year to Date Price ChangeUS$ -1.19
Year to Date Percent Change-75.8%

ZyVersa Therapeutics Inc. (ZVSA) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.10
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio0.30
Leverage Ratio1.10
Quick Ratio0.10
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 6,390,909
Price to Sales0.00
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book0.10
Price To Cash Flow-14.60
PE Low Last 5 Years-63.40
Price to Tangible Book0.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets0.00
Return on Equity0.00
Return on Capital-6.90

ZyVersa Therapeutics Inc. (ZVSA) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditor-
CEOStephen C. Glover
Employees-
Last Audit-
CIK0001859007
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address
Suite 208
,
Website
Facsimile-
Telephone-
Email-
Your Recent History
NASDAQ
ZVSA
ZyVersa Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20230606 06:20:38